Personalised nutrition intervention for breast cancer survivors based on individual molecular analyses (nutrigenetics, lipidomics and microbiomics)

Not Applicable

• Conditions: utritional and metabolic status, and well being of breast cancer survivors; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN13901439
• Lead Sponsor: AZTI - Member of the Basque Research & Technology Alliance

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-19
• Last Update Posted: 13 November 2023
• Study Completion: 2024-05-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

Breast cancer survivors (at least 6 months after treatment), with hormonal treatment

Exclusion Criteria

1. Metastasis
2. Severe malnutrition
3. Allergy to fish
4. Any difficulty to take supplements
5. Without gallbladder

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Metabolic status will be measured as the rebalance of the lipidomic analyses and other biochemical parameters (standard biochemistry parameters: blood cholesterol, TG.) together with anthropometric parameters at 6 and 12 months.<br>2. Well-being will be measured using validated questionaries (EORTC QLQ-30 or similar) at 6 and 12 months.<br>3. Improvements of dietary habits will be assessed by validated food frequency questionnaire (FFQ from predimed) at 6 and 12 months.

Secondary Outcome Measures

Name	Time	Method
Cancer recurrence: relapses will be measured at 12 months using patient records